Active · per the CBE, 1 October 2026

Hemo Invest

BE1008187613

Rechtspersoon Private limited company 1 establishment

Hemo Invest is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 9 April 2024, 1 establishment.

Geloeslaan(M) 4, 3630 Maasmechelen

Behind the company: Herman De Haan.

Active for

2 year, 5 months

Financials

Financial year 2025

Hemo Invest from Maasmechelen, company number BE1008187613, closed financial year 2025 with a result of € 784 after tax. For that financial year Hemo Invest recorded a gross margin of € 3,141 and equity of € 4,537. Compared with financial year 2024, the result moved from € 1,753 to € 784. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 4,537

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 784

▼ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,333

▲ 118% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2,537.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 245,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 281

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,333

▲ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
20242025Change 2024 → 2025
Gross margin € 3,862 € 3,141 ▼ 19%
Profit after taxes € 1,753 € 784 ▼ 55%
Equity € 3,753 € 4,537 ▲ 21%
Total debts € 251,211 € 252,869 ▲ 1%
Cash € 3,363 € 7,333 ▲ 118%
Retained profit € 1,753 € 2,537 ▲ 45%
Bank debt € 245,000 € 245,000
Balance sheet total € 254,964 € 257,406 ▲ 1%

Key figures of Hemo Invest, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Hemo Invest?

What happened at Hemo Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 784 (▼ 55% vs 2024). Source: NBB ↗
  • New establishment in Maasmechelen. KBO
  • Herman De Haan became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 1,753 profit in 2024 to € 784 profit in 2025.

Paid € 846 in corporate taxes since 2024.

Best year ever: 2024, with € 1,753 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Hemo Invest? We notify you, reason included.

Follow Hemo Invest

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

Herman De Haan
Hemo Invest
LPJ Retail 49%

Behind Hemo Invest is Herman De Haan. It owns 49% of LPJ Retail itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Herman De Haan

Statutaire Bestuurder

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Geloeslaan(M) 4

3630 Maasmechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1008.187.613
VAT number
BE 1008.187.613
Registered office
Geloeslaan(M) 4, 3630 Maasmechelen
Names & denominations
Hemo Invest
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
9 April 2024
Peppol
Active · Active since 14 Jan 2026
Activities · NACE

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does Hemo Invest do?
Hemo Invest is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 9 April 2024, 1 establishment.
What is the address of Hemo Invest?
The registered office of Hemo Invest is located at Geloeslaan(M) 4, 3630 Maasmechelen.
Is Hemo Invest still active?
Yes. According to the CBE (1 October 2026) Hemo Invest is active, legal situation “Normale toestand”, started on 9 April 2024.
Is Hemo Invest registered on Peppol?
Yes, Hemo Invest is registered on the Peppol network with ID 0208:1008187613.
What is the enterprise number of Hemo Invest?
The enterprise number of Hemo Invest is BE1008187613.
When was Hemo Invest founded?
Hemo Invest was founded on 9 April 2024.